Table 2:

Summarized table of Elagolix/ABT prescribed to women with uterine fibroids

Product	Elagolix/E2/NETA (300 mg/1 mg/0.5 mg) in the morning and Elagolix 300 mg in the evening
Common adverse events	Hot flushes Headache Metrorrhagia
Precaution	Liver diseases- Deep venous thrombosis- Hormonal dependent malignancies- Cardiac disorder- irregular bleeding- gall bladder disorders
Contraindications	Osteoporosis- uncontrolled hypertension- pregnancy- current liver or heart disease- current hormonal dependent malignancy.
Drug interactions	Strong CYP3A4 inducers and inhibitors OATP1B1 inhibitors CYP2C19 substrates P-glycoprotein substrates